CELLUREON MSC ELITE is our proprietary platform of post-partum, ethically sourced Wharton’s Jelly MSCs, developed through advanced isolation and expansion methods that preserve the cells' youthful phenotype, stability, and therapeutic potency.
Compared to bone marrow or adipose-derived MSCs, CELLUREON cells demonstrate a superior immunomodulatory profile and enhanced regenerative capacity — making them a powerful tool in the treatment of inflammation-driven and degenerative conditions.
Backed by over a decade of scientific innovation, our team has optimized commercial-scale manufacturing of these clinical-grade cells, with rigorous FDA-compliant testing for infectious agents and chromosomal stability.
CELLUREON represents a new standard in MSC-based therapies — delivering millions of viable, high-quality doses with proven biological consistency.

Usamos cookies para analizar el tráfico del sitio web y optimizar tu experiencia en el sitio. Al aceptar nuestro uso de cookies, tus datos se agruparán con los datos de todos los demás usuarios.